Atlas Trials

IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer

Clinical trial NCT03748680 · UNKNOWN

Trial details

NCT number
NCT03748680
Sponsor
Karen-Lise Garm Spindler
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal CancerCirculating Tumor DNAAdjuvant ChemotherapyProgression Free Survival
Start date
2018-10-01
Primary completion
2023-10-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.